Repository logo
 

Medulloblastoma genotype dictates blood brain barrier phenotype

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Phoenix, Timothy N 
Patmore, Deanna M 
Boop, Scott 
Boulos, Nidal 
Jacus, Megan O 

Abstract

The childhood brain tumor, medulloblastoma, includes four subtypes with very different prognoses. Here, we show that paracrine signals driven by mutant β-catenin in WNT-medulloblastoma, an essentially curable form of the disease, induce an aberrant fenestrated vasculature that permits the accumulation of high levels of intra-tumoral chemotherapy and a robust therapeutic response. In contrast, SHH-medulloblastoma, a less curable disease subtype, contains an intact blood brain barrier, rendering this tumor impermeable and resistant to chemotherapy. The medulloblastoma-endothelial cell paracrine axis can be manipulated in vivo, altering chemotherapy permeability and clinical response. Thus, medulloblastoma genotype dictates tumor vessel phenotype, explaining in part the disparate prognoses among medulloblastoma subtypes and suggesting an approach to enhance the chemoresponsiveness of other brain tumors.

Description

Keywords

Journal Title

Cancer Cell

Conference Name

Journal ISSN

Volume Title

Publisher

Elsevier (Cell Press)

Publisher DOI

Publisher URL

Sponsorship
NATIONAL CANCER INSTITUTE (R01CA129541)
NATIONAL CANCER INSTITUTE (P01CA096832)
This work was supported by grants from the NIH (R.J.G., P01CA96832 and P30CA021765), the American Lebanese Syrian Associated Charities and Cancer Research UK.